Literature DB >> 15264123

Paraneoplastic cholestasis associated with prostate carcinoma.

Mehmet Koruk1, Mehmet Büyükberber, Cemil Savaş, Abdurrahman Kadayifçi.   

Abstract

Paraneoplastic syndromes associated with prostate carcinoma are very rare. We report a patient with prostate carcinoma and cholestatic jaundice without biliary obstruction, hepatic involvement or infectious etiology. In the literature, only one case of idiopathic cholestatic jaundice with prostate carcinoma has been reported and a paraneoplastic etiology was suggested. In our case, cholestasis rapidly regressed with chemotherapy and the patient is well at six months of follow-up. Paraneoplastic cholestasis should be kept in mind in the absence of biliary tract obstruction, hepatic involvement or infectious etiology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15264123

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  13 in total

1.  Fulminant hepatic failure in a patient with advanced extragonadal germ cell tumour.

Authors:  Alison Young; Ayman Madi; Darren Treanor; Charles Millson; Peter Selby; John Chester
Journal:  BMJ Case Rep       Date:  2010-09-29

2.  Idiopathic cholestatic jaundice may be a paraneoplastic manifestation of underlying malignancy: a case of prostate cancer.

Authors:  Akihiro Okano; Masaya Ohana; Fusako Kusumi
Journal:  Clin J Gastroenterol       Date:  2014-04-12

3.  Cholestatic Jaundice as a Paraneoplastic Manifestation of Prostate Cancer Aggravated by Steroid Therapy.

Authors:  Min Kyu Kang; Jung Gil Park; Heon Ju Lee
Journal:  Med Princ Pract       Date:  2018-01-10       Impact factor: 1.927

4.  Obstructive jaundice as a presenting symptom of metastatic carcinoma of the prostate.

Authors:  Arun Sahai; Chee Wan Lai; Gabriel Constantinescu; Mohamed Y Hammadeh
Journal:  BMJ Case Rep       Date:  2009-08-20

Review 5.  Paraneoplastic syndromes in prostate cancer.

Authors:  Matthew K Hong; Jennifer Kong; Benjamin Namdarian; Anthony Longano; Jeremy Grummet; Christopher M Hovens; Anthony J Costello; Niall M Corcoran
Journal:  Nat Rev Urol       Date:  2010-12       Impact factor: 14.432

6.  Paraneoplastic hyperbilirubinemia in metastatic prostate cancer and review of the current literature.

Authors:  Pınar Gökçen; Kaan Gökçen; Erol Çakmak; Gökhan Gökçe
Journal:  Turk J Urol       Date:  2018-09-12

Review 7.  Farnesoid X receptor alpha: a molecular link between bile acids and steroid signaling?

Authors:  Marine Baptissart; Aurelie Vega; Emmanuelle Martinot; Silvère Baron; Jean-Marc A Lobaccaro; David H Volle
Journal:  Cell Mol Life Sci       Date:  2013-06-20       Impact factor: 9.261

8.  Hepatic Dysfunction as a Paraneoplastic Manifestation of Metastatic Prostate Adenocarcinoma.

Authors:  David Kato; Chinemerem Okwara; Christopher Moreland; Allan Parker
Journal:  J Investig Med High Impact Case Rep       Date:  2014-06-24

9.  Metastatic Prostate Cancer Manifesting as Cholestatic Jaundice: A Case Report and Review of the Literature.

Authors:  Deepak Ravindranathan; Emilie Elise Hitron; Greta Anne Russler; Yue Xue; Mehmet Asim Bilen
Journal:  Case Rep Oncol Med       Date:  2018-03-26

10.  Cholestatic jaundice as a paraneoplastic manifestation of prostate cancer.

Authors:  Tomomi Kuramoto; Hiroya Senzaki; Hiroyuki Koike; Kenji Yamagiwa; Shinobu Tamura; Tokuzou Fujimoto; Takeshi Inagaki
Journal:  Case Rep Urol       Date:  2013-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.